OnKure Therapeutics (OKUR) Earnings Analysis
OnKure Therapeutics (OKUR) next reports earnings on 2026-08-11, consensus EPS -0.58 USD. Last quarter (2026-03-12) it beat with EPS -0.99 USD vs -1.15 USD est (+13.9%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -1.00.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OKUR next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.58 USD |
| Revenue estimate | 0.00B |
OKUR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -0.99 USD | -1.15 USD | +13.9% | Beat |
| 2025-11-06 | -1.09 USD | -1.2 USD | +9.2% | Beat |
| 2025-03-10 | -1.37 USD | -0.86 USD | -59.3% | Miss |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
OKUR valuation and analyst view
| Trailing P/E | -1.00 |
|---|---|
| Trailing EPS | -4.29622 USD |
| Price / book | 0.32 |
| Dividend yield | 0.00% |
| Market cap | 0.06B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is OnKure Therapeutics (OKUR)'s next earnings date?
OnKure Therapeutics is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.58 USD and revenue estimate of 0.00B.
Did OKUR beat earnings last quarter?
In its 2026-03-12 report, OKUR posted EPS of -0.99 USD versus a -1.15 USD estimate — a beat of 13.9%.
What is OKUR's earnings track record?
Over the last 3 reported quarters with consensus data, OKUR beat estimates 2 times (67%).
What is OKUR's current P/E ratio and EPS?
OKUR trades at a trailing P/E of -1.00 on trailing EPS of -4.296220643607477 USD.
What do analysts rate OKUR?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).